Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sézary Syndrome: A Multicenter Phase II Study

PURPOSE: To assess the efficacy of pembrolizumab in patients with advanced relapsed or refractory mycosis fungoides (MF) or Sézary syndrome (SS). PATIENTS AND METHODS: CITN-10 is a single-arm, multicenter phase II trial of 24 patients with advanced MF or SS. Patients were treated with pembrolizumab...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Clin Oncol
Main Authors: Khodadoust, Michael S., Rook, Alain H., Porcu, Pierluigi, Foss, Francine, Moskowitz, Alison J., Shustov, Andrei, Shanbhag, Satish, Sokol, Lubomir, Fling, Steven P., Ramchurren, Nirasha, Pierce, Robert, Davis, Asa, Shine, Richard, Li, Shufeng, Fong, Sophia, Kim, Jinah, Yang, Yi, Blumenschein, Wendy M., Yearley, Jennifer H., Das, Biswajit, Patidar, Rajesh, Datta, Vivekananda, Cantu, Erin, McCutcheon, Justine N., Karlovich, Chris, Williams, P. Mickey, Subrahmanyam, Priyanka B., Maecker, Holden T., Horwitz, Steven M., Sharon, Elad, Kohrt, Holbrook E., Cheever, Martin A., Kim, Youn H.
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Clinical Oncology 2020
Assuntos:
ORIGINAL REPORTS
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6943974/
https://ncbi.nlm.nih.gov/pubmed/31532724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.01056
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares